Viral Hepatitis Elimination Program in Ukraine

Viral Hepatitis Elimination Program in Ukraine

Virus targets
Hepatitis B
Hepatitis C
Type
Implementation
Technical assistance
Setting
National
Other targets
HIV
Phase
Active
Health outcomes
Incidence
Mortality
WHO region
European Region
Country
Ukraine
Key interventions
Blood safety
Community mobilization
Hepatitis B Vaccination
Injection safety and infection control
Persons who inject drugs: HCV cure as prevention
Persons who inject drugs: Medication assisted therapy
Persons who inject drugs: Syringe service program(s)
Prevention mother-child transmission
Strategic data analysis
Testing and diagnosis
Treatment (direct or referral)
Target population
Adolescents (10 - 19 years of age)
Adults (> 19 years of age)
Blood transfusion recipients
Children (> one year < 10 years of age)
Incarcerated populations (current and former)
Infants (less than one year of age)
Men who have sex with men
Newborn (born in last 30 days)
Occupations with possible exposure
Persons who inject drugs
Pregnant women
Performance target
Blood safety
Care cascade: HBV diagnosis
Care cascade: HBV testing
Care cascade: HBV treatment
Care cascade: HCV diagnosis
Care cascade: HCV testing
Care cascade: HCV treatment
Harm reduction (access to safe injection equipment for persons who inject drugs)
HBV prevention of mother to child transmission
Hepatitis B vaccination coverage
Injection safety
If you would like to have a program page for your program, please create an account and submit program information here

Health outcomes additional info

To reduce an incidence - 90%, mortality - 65%; HBV vaccination - 90%, prevention HBV transmission from mother to child - 90%, blood safety - 100% donor blood checked, safe injections - 90%, harm reduction - 300 syringes per year, HBV/HCV diagnostic - 90%, 80% people with chronic HBV and HCV

Performance target additional info

To reduce an incidence - 30%, mortality - 10%; HBV vaccination - 90%, prevention HBV transmission from mother to child - 50%, blood safety - 95% donor blood checked, safe injections - 50%, harm reduction - 200 syringes per year, HBV/HCV diagnostic - 30%, HBV treatment - 5 mln people and HCV treatment - 3 mln people

Last updated